Influence of cobalamin on arsenic metabolism in Bangladesh

Environmental Health Perspectives

Volumn 117, Issue 11, 2009, Pages 1724-1729

  Hall, Megan N ^a   Liu, Xinhua ^a   Slavkovich, Vesna ^a   Ilievski, Vesna ^a   Mi, Zhongyuan ^a   Alam, Shafiul ^b   Factor Litvak, Pam ^a   Ahsan, Habibul ^a,c   Graziano, Joseph H ^a   Gamble, Mary V ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (Bangladesh)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Arsenic; Bangladesh; Cobalamin; Creatinine; Dimethylarsinic acid; Folate; Homocysteine; Monomethylarsonic acid; One carbon metabolism

Indexed keywords

ARSENIC; CACODYLIC ACID; COBALAMIN; CREATININE; FOLIC ACID; METHANEARSONIC ACID; METHYL GROUP;

ADULT; ARTICLE; BANGLADESH; BLOOD LEVEL; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLISM; METABOLITE; METHYLATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ARSENIC; ARSENICALS; BANGLADESH; CACODYLIC ACID; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; FOLIC ACID; HUMANS; MALE; MIDDLE AGED; VITAMIN B 12; WATER POLLUTANTS, CHEMICAL; YOUNG ADULT;

EID: 74949110494     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0900734     Document Type: Article

References (37)

1. Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, et al. 2007. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev 16(6):1270-1278.
2. California EPA. 2004. Office of Environmental Health Hazard Assessment. Public Health Goal for Arsenic in Drinking Water. Available: http://oehha.ca.gov/water/phg/pdf/asfinal. pdf [accessed 10 January 2009].
3. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, et al. 2003a. Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med 45(3):241-248.
4. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, et al. 2003b. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14(4):303-310; doi:10.1023/ A:1023905900171 [Online 2 November 2004].
5. Cheng Z, Zheng Y, Mortlock R, Van Geen A. 2004. Rapid multi-element analysis of groundwater by high-resolution inductively coupled plasma mass spectrometry. Anal Bioanal Chem 379(3):512-518; doi:10.1007/s00216-004-2618-x [Online 19 April 2004].
6. Christenson RH, Dent GA, Tuszynski A. 1985. Two radioassays for serum vitamin B12 and folate determination compared in a reference interval study. Clin Chem 31(8):1358-1360.
7. Chung JS, Haque R, Guha Mazumder DN, Moore LE, Ghosh N, Samanta S, et al. 2006. Blood concentrations of methionine, selenium, beta-carotene, and other micronutrients in a case-control study of arsenic-induced skin lesions in West Bengal, India. Environ Res 101(2):230-237; doi:10.1016/j.envres.2005.10.006 [Online 5 December 2005].
8. Clarke R, Sherliker P, Hin H, Nexo E, Hvas AM, Schneede J, et al. 2007. Detection of vitamin B12 deficiency in older people by measuring vitamin B12 or the active fraction of vitamin B12, holotranscobalamin. Clin Chem 53(5):963-970.
9. Drobna Z, Naranmandura H, Kubachka KM, Edwards BC, Herbin-Davis K, Styblo M, et al. 2009. Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally adminis tered arsenate. Chem Res Toxicol 10.1021/tx900179r [Online 20 August 2009].
10. Drobna Z, Xing W, Thomas DJ, Styblo M. 2006. shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. Chem Res Toxicol 19(7):894-898; doi:10.1021/tx060076u [Online 28 June 2006].
11. Gamble MV, Ahsan H, Liu X, Factor-Litvak P, Ilievski V, Slavkovich V, et al. 2005a. Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh. Am J Clin Nutr 81(6):1372-1377.
12. Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, et al. 2006. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr 84(5):1093-1101.
13. Gamble MV, Liu X, Ahsan H, Pilsner R, Ilievski V, Slavkovich V, et al. 2005b. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 113:1683-1688; doi:10.1289/ehp.8084 [Online 21 July 2005].
14. Gamble MV, Liu X, Slavkovich V, Pilsner JR, Ilievski V, Factor-Litvak P, et al. 2007. Folic acid supplementation lowers blood arsenic. Am J Clin Nutr 86(4):1202-1209.
15. Hall M, Gamble M, Slavkovich V, Liu X, Levy D, Cheng Z, et al. 2007. Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect 115:1503-1509; doi:10.1289/ehp.9906 [Online 28 June 2007].
16. Heck JE, Gamble MV, Chen Y, Graziano JH, Slavkovich V, Parvez F, et al. 2007. Consumption of folate-related nutrients and metabolism of arsenic in Bangladesh. Am J Clin Nutr 85(5):1367-1374.
17. Huang YK, Huang YL, Hsueh YM, Yang MH, Wu MM, Chen SY, et al. 2008. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Cancer Causes Control 19(8):829-839; doi:10.1007/s10552-008-9146-5 [Online 20 March 2008].
18. Kinniburgh DG, Smedley PL. 2001. Arsenic contamination of groundwater in Bangladesh. Final Report. BGS Technical Report. Keyworth, U.K. Available: http://www.bgs.ac.uk/ arsenic/bphase2/reports.htm [accessed 12 January 2009].
19. Li L, Ekstrom EC, Goessler W, Lonnerdal B, Nermell B, Yunus M, et al. 2008. Nutritional status has marginal influence on the metabolism of inorganic arsenic in pregnant Bangladeshi women. Environ Health Perspect 116:315-321; doi:10.1289/ ehp.10639. [Online 19 November 2007].
20. Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, et al. 2002. A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem 277(13):10795-10803; doi:10.1074/jbc. M110246200. [Online 14 January 2002].
21. Marafante E, Vahter M. 1984. The effect of methyltransferase inhibition on the metabolism of [74As]arsenite in mice and rabbits. Chem Biol Interact 50(1):49-57.
22. Navarro Silvera SA, Rohan TE. 2007. Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control 18(1):7-27; doi:10.1007/s10552-006-0057-z [Online 22 December 2006].
23. Nixon DE, Mussmann GV, Eckdahl SJ, Moyer TP. 1991. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem 37(9):1575-1579.
24. Obeid R, Herrmann W. 2007. Holotranscobalamin in laboratory diagnosis of cobalamin deficiency compared to total cobalamin and methylmalonic acid. Clin Chem Lab Med 45(12):1746-1750.
25. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. 2005. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 82(2):442-450.
26. Pfeiffer CM, Huff DL, Gunter EW. 1999. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45(2):290-292.
27. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, et al. 2009. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect 117:254-260; doi:10.1289/ehp.11872 [Online 26 September 2008].
28. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, et al. 1999. Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 131(5):331-339.
29. Slot C. 1965. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17(4):381-387.
30. Spiegelstein O, Lu X, Le XC, Troen A, Selhub J, Melnyk S, et al. 2003. Effects of dietary folate intake and folate binding protein-1 (Folbp1) on urinary speciation of sodium arsenate in mice. Toxicol Lett 145(2):167-174; doi:10.1016/S0378-4274(03)00307-2 [Online 6 September 2003].
31. Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ. 2002. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect 110(suppl 5):767-771.
32. Tseng CH. 2007. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 25(1):1-22.
33. Vahter M, Marafante E. 1987. Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett 37(1):41-46.
34. Wang TC, Jan KY, Wang AS, Gurr JR. 2007. Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells. Mutat Res 615(1-2):75-86; doi:10.1016/j.mrfmmm.2006.10.003 [Online 28 November 2006].
35. Zablotska LB, Chen Y, Graziano JH, Parvez F, van Geen A, Howe GR, et al. 2008. Protective effects of B vitamins and antioxidants on the risk of arsenic-related skin lesions in Bangladesh. Environ Health Perspect 116(8):1056-1062; doi:10.1289/ehp.10707 [Online 16 April 2008].
36. Zakharyan RA, Aposhian HV. 1999. Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. Toxicol Appl Pharmacol 154(3):287-291.
37. Zeisel SH. 2006. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr 26:229-250; doi:10.1146/annurev. nutr.26.061505.111156 [Online 9 May 2006].